Chemotherapy of neuroblastoma in mice with anticancer agents
β Scribed by George C. Y. Chiou; Marilyn K. Martin
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 345 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Bromoacetylcholine (30 mg/kg intratumor one to three times per day) and bromoacetate (12 mg/kg intratumor two times per day) inhibited neuroblastoma in A/J mice efficiently and prolonged the lifespan of these animals at least 200%. Since the neuroblastoma-inoculated A/J mice are considered to be com
A retrospective analysis of 46 histologically proven cases of neuroblastoma is presented. The over-all 2-year survival was 46%. All except 1 of the 21 patients surviving 2 years were continuously free of clinical and laboratory evidence of neuroblastoma. The patients treated before 1967 were treated
Since alpha B-crystallin is known to be expressed in glial tissues of human brain and neuroectodermal tumors, the alpha B-crystallin content of neuroblastomas, may be related to the degree of glial or neuronal differentiation. The alpha B-crystallin content of 73 neuroblastomas, was determined by en
## Abstract Angiogenesis is an essential process for tumor growth and is regulated by tumorβderived angiogenic cytokines. Osteopontin (OPN) is one of the cytokines produced by various tumor cells and is suggested to be involved in angiogenesis by upregulating endothelial cell migration in cooperati